Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation

Cytotherapy

Volumn 6, Issue 6, 2004, Pages 571-583

  Ojeda Uribe, Mario ^a,b   Sovalat, H ^a   Bourderout, D ^a   Brunot, A ^a   Marr, A ^a   Lewandowski, H ^a   Chaboute V ^a   Peter, P ^a   Henon, Ph ^a  

^a CENTRE HOSPITALIER DE MULHOUSE   (France)

^b Hôpitaux Universitaires de Strasbourg   (France)

Author keywords

Autologous stem cell transplantation; Cryopreservation; Hematopoietic reconstitution; Hematopoietic stem cells

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; DIMETHYL SULFOXIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER PATIENT; CELL COUNT; CELL LOSS; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; FREEZING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREDICTION; STATISTICAL ANALYSIS; THAWING;

EID: 11144271507     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/14653240410011918     Document Type: Article

References (45)

1. Appelbaum FR, Herzig GP, Ziegler JL et al. Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood 1978;52:85-95.
2. Goldman JM, Schmitz N, Diethammer D, Gratwohl A. for the Accreditation sub-committee of the European Group for Blood and Marrow Transplantation (EBMT). Allogeneic and autologous transplantation for haematological diseases, solid tumors and immune disorders: current practice in Europe in 1997. Bone Marrow Transplant 1998;21:1-7.
3. + dose in peripheral blood progenitor transplantation for non-Hodgkin lymphoma patients: a single centre study. Bone Marrow Transplant 2000;25:997-1002.
4. - cells in early and late trilineage haemopoietic engraftment after autologous blood cell transplantation. Br J Haematol 1998;103:568-81.
5. Bensinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral blood stem cells. J Clin Oncol 1995;13:2547-55.
6. Desikan KR, Tricot G, Munshi NC et al. Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone. Br J Haematol 2001;112:242-7.
7. Weaver CH, Hazelton B, Birch R et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86:3961-9.
8. - cells influence days to engraftment and transfusion requirements in autologous blood-stem cell recipients. J Clin Oncol 1998;16:2093-104.
9. + cell counts based on the ISHAGE. Cytometry 1998;34:61-70.
10. - and week-6 CAFC assays predict poor engraftment. Exp Hematol 2000;28:1325-33.
11. Gonzales-Requejo A, Madero L, Diaz MA et al. Progenitor cell subsets and engraftment kinetics in children undergoing autologous peripheral blood stem cell transplantation. Br J Haematol 1998;101:104-10.
12. null mice. Blood 2001;97:3283-91.
13. Larochelle A, Vormoor J, Hanenberg H et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mice using retroviral gene marking and cell purification:implications for gene therapy. Nat Med 1996; 2:1329-37.
14. Bathia M, Wang JC, Kapp U et al. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 1997;94:5320-5.
15. Cilloni D, Garau D, Regazzi E et al. Primitive hematopoictic progenitors within mobilized blood are spared by uncontroled rate freezing. Bone Marrow Transplant 1999;23:497-503.
16. Pettengel R, Woll PJ, O'Connor DA et al. Viability of haematopoietic progenitors from whole blood, bone marrow and leukapheresis product: effects of storage media, temperature and time. Bone Marrow Transplant 1994;14:703-9.
17. + cells. Transfusion 2003:43: 878-84.
18. + hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis. Cytometry 1998; 13:135-43.
19. - subset from mobilized blood show different patterns of adhesion molecules compared to those from steady-state blood, bone marrow and cord blood. J Hematother Stem Cell Res 2003;12:473-89.
20. - progenitor cells. Blood 1991;77:1218-27.
21. Siegel S. Non parametric statistics for the behavioural sciences. New York: McGraw-Hill; 1956.
22. Gorlin J. Stem cell cryopreservation. J Infusion Chemother 1996;6:23-27.
23. Rowley SD. Hematopoietic stem cell cryopreservation: a review of current techniques. J Hematother 1992;1:233-50.
24. Gao DY, Chang Q, Liu C et al. Fundamental cryobiology of human hematopoietic progenitor cells. I. Osmotic characteristics and volume distribution. Cryobiology 1998;36:40-8.
25. Civin C, Almeida-Porada G, Lee MJ et al. Sustained, retransplantable, multilineage engraftment of highly purified adult bone marrow stem cells in vivo. Blood 1996;88:4102-9.
26. + cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1- subset following cell division ex vivo. Exp Hematol 1999;27:994-1003.
27. + cells. Exp Hematol 1998;26:353-60.
28. - with engraftment post-PBSC transplantation (correspondence). Br J Hematol 1999;104:643-4.
29. Gordon B, Tarantolo S, Ruby E et al. Increased platelet transfusion requirement is associated with multiple organ dysfunctions in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 1998;22:675-9.
30. + cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2002;29:967-72.
31. De Boer F, Drager AM, Pinedo HM et al. Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant 2002;29:249-55.
32. Xiao M, Dooley D. Assessment of cell viability and apoptosis in human umbilical cord blood following storage. J Hematother Stem Cell Res 2003;12:115-22.
33. Moroff G, Seetharaman S, Kurtz J et al. Retention of cellular properties of PBPCs following liquid storage and cryopreservation. Transfusion 2004;44:245-52.
34. + cells to dimethyl sulphoxide. Cryobiology 2003;46:61-75.
35. + cells to multimolar dimethyl sulphoxide and the effect of cooling rate on recovery after freezing and thawing. Cryobiology 2003;46:76-87.
36. Panterne B, Sabatini C, Huyghe G et al. External quality control of hematopoietic progenitor cell products 1999-2003 (in French, abstract). Transfusion Clinique et Biologique 2003; 10(suppl 1):88S.
37. DiGiusto DL, Lee R, Moon J et al. Hematopoietic potential of cryopreserved and ex-vivo manipulated umbilical cord blood progenitor cells evaluated ex vivo and in vivo. Blood 1996;87:1261-71.
38. Timeus F, Crescenzio N, Saracco P et al. Recovery of cord blood hematopoietic progenitors after successive freezing and thawing procedures. Haematologica 2003;88:74-9.
39. Rosillo MC, Ortuno F, Rivera J et al. Cryopreservation modifies flow-cytometric analysis of hematopoietic cells. Vox Sang 1995;68:210-4.
40. Hubel A, Carlquist D, Clay M, McCullough J. Liquid storage, shipment and cryopreservation of cord blood. Transfusion 2004;44:518-25.
41. Chaudary PM, Roninson IB. Expression and activity of p-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 1991;66:85-94.
42. Broxmeyer HE, Srour EF, Giao H et al. High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc Natl Acad Sci USA 2003;100:645-50.
43. + cells and their application to cryopreservation. J Hematother Stem Cell Res 2000;9:161-73.
44. Hubel A, Norman J, Darr TB. Cryobiophysical characteristics of genetically modified hematopoietic progenitor cells. Cryobiology 1999;38:140-53.
45. Goodell MA, Jackson KA, Majka SM et al. Stem cell plasticity in muscle and bone marrow. Ann NY Acad Sci 2001;938: 208-18.